Atea Pharmaceuticals
AVIR
AVIR
132 hedge funds and large institutions have $213M invested in Atea Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 41 increasing their positions, 39 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
132
Holders Change
+3
Holders Change %
+2.33%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
28
Increased
41
Reduced
39
Closed
24
Calls
$341K
Puts
$247K
Net Calls
+$94K
Net Calls Change
-$45K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
KI
151
Kapitalo Investimentos
Sao Paulo,
Brazil
| – | -$41.9K | -12,500 | Closed |
|
152
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$40K | -11,955 | Closed |
|
153
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$1.34K | -400 | Closed |
|
|
ASN
154
Advisory Services Network
Atlanta,
Georgia
| – | -$670 | -200 | Closed |
|
|
QCG
155
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$195 | -58 | Closed |
|